Related references
Note: Only part of the references are listed.Tau phosphorylation: the therapeutic challenge for neurodegenerative disease
Diane P. Hanger et al.
TRENDS IN MOLECULAR MEDICINE (2009)
Mechanisms of A beta mediated neurodegeneration in Alzheimer's disease
Peter J. Crouch et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
Medical progress: Age-related macular degeneration
Rama D. Jager et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Cell-cycle reentry and cell death in transgenic mice expressing nonmutant human tau isoforms
C Andorfer et al.
JOURNAL OF NEUROSCIENCE (2005)
Protein aggregation in retinal cells and approaches to cell protection
I Surgucheva et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2005)
Tissue inhibitor of metalloproteinases-3 (TIMP-3) is a binding partner of epithelial growth factor-containing fibulin-like extracellular matrix protein 1 (EFEMP1) - Implications for macular degenerations
PA Klenotic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
The chaperone environment at the cytoplasmic face of the endoplasmic reticulum can modulate rhodopsin processing and inclusion formation
JP Chapple et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2003)
Protein turnover by the proteasome in aging and disease
R Shringarpure et al.
FREE RADICAL BIOLOGY AND MEDICINE (2002)
Unfolding retinal dystrophies: a role for molecular chaperones?
JP Chapple et al.
TRENDS IN MOLECULAR MEDICINE (2001)
Synucleins in ocular tissues
A Surguchov et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2001)
Impairment of the ubiquitin-proteasome system by protein aggregation
NF Bence et al.
SCIENCE (2001)
Cellular defenses against unfolded proteins: A cell biologist thinks about neurodegenerative diseases
MY Sherman et al.
NEURON (2001)
Share Paper
